APA

Sandler S. G., Flegel W. A., Westhoff C. M., Denomme G. A., Delaney M., Keller M. A., Johnson S. T., Katz L., Queenan J. T., Vassallo R. R. & Simon C. D. (20150519). It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. : Transfusion.

Chicago

Sandler S Gerald, Flegel Willy A, Westhoff Connie M, Denomme Gregory A, Delaney Meghan, Keller Margaret A, Johnson Susan T, Katz Louis, Queenan John T, Vassallo Ralph R and Simon Clayton D. 20150519. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. : Transfusion.

Harvard

Sandler S. G., Flegel W. A., Westhoff C. M., Denomme G. A., Delaney M., Keller M. A., Johnson S. T., Katz L., Queenan J. T., Vassallo R. R. and Simon C. D. (20150519). It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. : Transfusion.

MLA

Sandler S Gerald, Flegel Willy A, Westhoff Connie M, Denomme Gregory A, Delaney Meghan, Keller Margaret A, Johnson Susan T, Katz Louis, Queenan John T, Vassallo Ralph R and Simon Clayton D. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. : Transfusion. 20150519.